Carol A Kemper, MD
Infectious Disease · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: 757662 · El Camino Health. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kemper’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G60294 · Current
Licensed to practise in California · since 1987 · expires 2027-02-28 · University of Minnesota Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$52,387
Medicare paid this office $52,387 for 151 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 114 | $27,027 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 61 | $9,974 | $156 |
| Long return visit (40+ min) | 32 | $6,746 | $165 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $3,396 | $69 |
| Return visit (30+ min) | 21 | $2,950 | $113 |
Who their Medicare patients are
151 Original Medicare patients in 2024. Average age 77 · Under 65 8% · 85 and older 27% · Women 43% · Also on Medicaid 22% · Health risk score 2.86. At or below the middle of the specialty; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 75% · Coronary heart disease 49% · Chronic kidney disease 48% · Heart failure 45% · Diabetes 43% · Atrial fibrillation 42% · Depression 36% · COPD 35% · Dementia 28% · Cancer 26% · Stroke 17%.
The office billed $189,817, Medicare allowed $66,670 and paid $52,387; for 460 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 151 | 460 | 77 | 2.86 | $189,817 | $52,387 |
| 2023 | 136 | 440 | 79 | 2.34 | $177,608 | $50,737 |
| 2022 | 142 | 521 | 77 | 3.03 | $203,838 | $56,657 |
| 2021 | 176 | 680 | 76 | 2.70 | $249,905 | $72,412 |
| 2020 | 212 | 884 | 76 | 3.13 | $275,216 | $90,192 |
| 2019 | 214 | 692 | 76 | 3.05 | $238,186 | $71,811 |
| 2018 | 202 | 726 | 76 | 3.00 | $242,743 | $73,621 |
| 2017 | 182 | 597 | 74 | 2.80 | $187,405 | $58,294 |
| 2016 | 182 | 792 | 74 | 2.58 | $224,756 | $70,412 |
| 2015 | 181 | 722 | 74 | 2.79 | $218,975 | $70,533 |
| 2014 | 246 | 939 | 70 | 2.41 | $260,920 | $80,331 |
| 2013 | 184 | 1,191 | 70 | 2.22 | $210,613 | $60,673 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 104 | $26,664 | $110 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 54 | $8,655 | $157 |
| Long return visit (40+ min) | 24 | $5,836 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $3,922 | $73 |
| Return visit (30+ min) | 11 | $2,072 | $122 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $587 | $45 |
2022: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 107 | $29,081 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 69 | $13,011 | $183 |
| Long return visit (40+ min) | 25 | $5,229 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $3,684 | $65 |
| Return visit (30+ min) | 16 | $2,695 | $128 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $663 | $37 |
2021: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 124 | $34,179 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 85 | $17,327 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 82 | $8,702 | $68 |
| Long return visit (40+ min) | 28 | $6,060 | $173 |
| Return visit (30+ min) | 11 | $1,529 | $127 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 35 | $1,373 | $36 |
2020: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 147 | $47,511 | $103 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 94 | $19,445 | $200 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 89 | $9,081 | $70 |
| Long return visit (40+ min) | 28 | $5,675 | $138 |
| Critical care, first 30-74 minutes | 11 | $2,538 | $212 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 28 | $1,481 | $39 |
| Return visit (30+ min) | 13 | $1,328 | $102 |
2019: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 141 | $33,986 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 84 | $15,228 | $179 |
| Long return visit (40+ min) | 41 | $8,700 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 62 | $5,833 | $66 |
| Return visit (30+ min) | 26 | $3,729 | $101 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $806 | $35 |
2018: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 131 | $36,036 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 80 | $15,092 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 76 | $7,191 | $65 |
| Long return visit (40+ min) | 34 | $6,823 | $129 |
| Return visit (30+ min) | 27 | $4,052 | $92 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $420 | $35 |
2017: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 108 | $25,921 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $9,790 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 71 | $7,126 | $65 |
| Long return visit (40+ min) | 29 | $6,006 | $131 |
| Return visit (30+ min) | 30 | $4,646 | $89 |
| Short return visit (20+ min) | 14 | $1,177 | $65 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $594 | $35 |
2016: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 99 | $27,580 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 90 | $14,108 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 62 | $11,717 | $180 |
| Long return visit (40+ min) | 42 | $7,439 | $131 |
| Return visit (30+ min) | 34 | $5,328 | $99 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 27 | $1,601 | $35 |
| Short return visit (20+ min) | 12 | $899 | $53 |
2015: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 98 | $27,621 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $11,236 | $187 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 84 | $10,592 | $67 |
| Return visit (30+ min) | 43 | $8,056 | $94 |
| Long return visit (40+ min) | 31 | $5,695 | $124 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,541 | $127 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 25 | $1,095 | $36 |
2014: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 108 | $22,179 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 107 | $14,348 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 63 | $12,012 | $179 |
| Long return visit (40+ min) | 59 | $10,702 | $123 |
| Return visit (30+ min) | 65 | $9,904 | $90 |
| Short return visit (20+ min) | 42 | $4,059 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,704 | $122 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 30 | $1,596 | $35 |
| Administration of influenza virus vaccine | 17 | $538 | $32 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 15 | $248 | $17 |
2013: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 80 | $19,690 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $11,025 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 71 | $10,301 | $61 |
| Long return visit (40+ min) | 39 | $6,228 | $118 |
| Return visit (30+ min) | 35 | $4,965 | $95 |
| Short return visit (20+ min) | 19 | $1,683 | $58 |
| Return visit (30+ min) | 21 | $1,639 | $59 |
| Long return visit (40+ min) | 11 | $671 | $45 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $652 | $33 |
Medicaid work
$1,765 in 2021
Medicaid paid $1,765 for 24 billed services this clinician did in 2021, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 24 | $1,765 |
| 2021 | 24 | 1 | 15 | $1,765 |
| 2020 | 55 | 1 | 14 | $989 |
See the largest Medicaid services in earlier years
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 55 | $989 |
Drugs they prescribed that Part D paid
$118,123
Pharmacies billed $118,123 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 230) in 2024. At or below the middle of the specialty; the typical infectious disease clinician is at 0%.
194 generic and 36 brand-name prescriptions · $118,123 in drug cost · 140 antibiotic prescriptions to 30 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Biktarvy | 14 | $63,639 | $4,546 |
| Descovy | 13 | $32,526 | $2,502 |
| Ampicillin | 13 | $2,711 | $209 |
| Ceftriaxone | 29 | $1,741 | $60 |
| Vancomycin | 17 | $1,726 | $102 |
See all 7 drugs
| Biktarvy | 14 | $63,639 | $4,546 |
| Descovy | 13 | $32,526 | $2,502 |
| Ampicillin | 13 | $2,711 | $209 |
| Ceftriaxone | 29 | $1,741 | $60 |
| Vancomycin | 17 | $1,726 | $102 |
| Fluconazole | 15 | $590 | $39 |
| Doxycycline Hyclate | 16 | $539 | $34 |
Year by year
| 2024 | 230 | 41 | 0% (0) | 16% | $118,123 |
| 2023 | 235 | 39 | 0% (0) | 14% | $113,111 |
| 2022 | 222 | 42 | 0% (0) | None | $86,609 |
| 2021 | 191 | 42 | 0% (0) | None | $85,025 |
| 2020 | 301 | 47 | None | 13% | $182,250 |
| 2019 | 268 | 49 | 0% (0) | 16% | $90,040 |
| 2018 | 271 | 39 | None | 28% | $77,320 |
| 2017 | 285 | 44 | 0% (0) | 26% | $143,461 |
| 2016 | 308 | 60 | None | 23% | $117,713 |
| 2015 | 807 | 89 | None | 40% | $358,051 |
| 2014 | 1,122 | 86 | 2% (19) | None | $520,386 |
| 2013 | 1,039 | 74 | None | 55% | $477,985 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Descovy | 11 | $25,616 | $2,329 |
| Ceftriaxone | 80 | $2,991 | $37 |
2022: 6 drugs
| Atovaquone | 15 | $11,559 | $771 |
| Cefepime | 24 | $10,015 | $417 |
| Ampicillin-Sulbactam | 37 | $3,084 | $83 |
| Vancomycin | 12 | $2,495 | $208 |
| Minocycline | 12 | $1,001 | $83 |
| Ceftriaxone | 29 | $742 | $26 |
2021: 6 drugs
| Oxacillin | 14 | $11,509 | $822 |
| Doxycycline Hyclate | 22 | $3,153 | $143 |
| Cefepime | 15 | $2,495 | $166 |
| Vancomycin | 17 | $2,429 | $143 |
| Rifampin | 25 | $2,108 | $84 |
| Minocycline | 17 | $842 | $50 |
2020: 10 drugs
| Daptomycin | 14 | $56,708 | $4,051 |
| Rifampin | 40 | $5,849 | $146 |
| Vancomycin | 24 | $5,033 | $210 |
| Ceftriaxone | 39 | $4,244 | $109 |
| Fluconazole | 13 | $3,211 | $247 |
| Ethambutol | 16 | $1,314 | $82 |
| Doxycycline Hyclate | 16 | $1,292 | $81 |
| Azithromycin | 11 | $930 | $85 |
| Minocycline | 18 | $793 | $44 |
| Dicloxacillin | 12 | $752 | $63 |
2019: 7 drugs
| Rifampin | 37 | $3,225 | $87 |
| Vancomycin | 21 | $2,572 | $122 |
| Ceftriaxone | 18 | $2,262 | $126 |
| Ethambutol | 34 | $1,785 | $52 |
| Azithromycin | 17 | $1,011 | $59 |
| Minocycline | 15 | $920 | $61 |
| Dicloxacillin | 12 | $690 | $58 |
2018: 10 drugs
| Prezcobix | 13 | $23,681 | $1,822 |
| Truvada | 13 | $21,966 | $1,690 |
| Vancomycin | 12 | $2,502 | $208 |
| Rifampin | 30 | $1,800 | $60 |
| Ceftriaxone | 22 | $1,752 | $80 |
| Ethambutol | 26 | $1,598 | $61 |
| Minocycline | 13 | $1,021 | $79 |
| Azithromycin | 18 | $964 | $54 |
| Levocarnitine | 12 | $510 | $43 |
| Acyclovir | 17 | $236 | $14 |
2017: 11 drugs
| Prezcobix | 12 | $20,261 | $1,688 |
| Truvada | 12 | $18,984 | $1,582 |
| Vancomycin | 16 | $3,299 | $206 |
| Meropenem | 11 | $2,500 | $227 |
| Ethambutol | 28 | $1,528 | $55 |
| Minocycline | 22 | $1,437 | $65 |
| Azithromycin | 19 | $1,284 | $68 |
| Rifampin | 22 | $1,239 | $56 |
| Levocarnitine | 12 | $477 | $40 |
| Acyclovir | 16 | $254 | $16 |
| Isoniazid | 11 | $69 | $6 |
2016: 12 drugs
| Rifabutin | 17 | $20,883 | $1,228 |
| Truvada | 12 | $17,856 | $1,488 |
| Prezcobix | 11 | $17,319 | $1,574 |
| Voriconazole | 12 | $7,536 | $628 |
| Vancomycin | 18 | $2,662 | $148 |
| Azithromycin | 20 | $2,040 | $102 |
| Ethambutol | 22 | $1,756 | $80 |
| Ceftriaxone | 17 | $843 | $50 |
| Levocarnitine | 11 | $407 | $37 |
| Minocycline | 19 | $333 | $18 |
| Ciprofloxacin | 20 | $298 | $15 |
| Acyclovir | 16 | $260 | $16 |
2015: 22 drugs
| Truvada | 44 | $55,970 | $1,272 |
| Prezista | 29 | $35,121 | $1,211 |
| Lexiva | 14 | $28,433 | $2,031 |
| Isentress | 23 | $26,714 | $1,161 |
| Reyataz | 16 | $19,784 | $1,236 |
| Intelence | 17 | $14,737 | $867 |
| Norvir | 43 | $14,207 | $330 |
| Androgel | 12 | $4,747 | $396 |
| Vancomycin | 25 | $2,258 | $90 |
| Fluconazole | 12 | $1,302 | $109 |
| Azithromycin | 16 | $692 | $43 |
| Ethambutol | 12 | $673 | $56 |
| Acyclovir | 24 | $415 | $17 |
| Tamsulosin | 14 | $342 | $24 |
| Levofloxacin | 20 | $175 | $9 |
| Minocycline | 12 | $162 | $13 |
| Levothyroxine | 12 | $154 | $13 |
| Sulfamethoxazole-Trimethoprim | 12 | $153 | $13 |
| Atorvastatin | 12 | $92 | $8 |
| Isoniazid | 19 | $87 | $5 |
| Escitalopram | 13 | $82 | $6 |
| Trazodone | 13 | $64 | $5 |
2014: 30 drugs
| Truvada | 76 | $86,106 | $1,133 |
| Prezista | 43 | $47,630 | $1,108 |
| Isentress | 35 | $38,131 | $1,089 |
| Reyataz | 35 | $37,009 | $1,057 |
| Intelence | 35 | $35,531 | $1,015 |
| Epzicom | 25 | $28,493 | $1,140 |
| Lexiva | 12 | $22,998 | $1,916 |
| Norvir | 68 | $21,874 | $322 |
| Sustiva | 24 | $17,453 | $727 |
| Kaletra | 15 | $12,478 | $832 |
| Combivir | 12 | $10,181 | $848 |
| Viread | 15 | $2,651 | $177 |
| Doxycycline Hyclate | 16 | $1,789 | $112 |
| Avodart | 11 | $1,578 | $143 |
| Ethambutol | 13 | $1,142 | $88 |
| Azithromycin | 26 | $967 | $37 |
| Famciclovir | 11 | $859 | $78 |
| Acyclovir | 22 | $509 | $23 |
| Pravastatin | 25 | $500 | $20 |
| Fenofibrate | 11 | $385 | $35 |
| Atorvastatin | 31 | $348 | $11 |
| Levothyroxine | 25 | $315 | $13 |
| Pantoprazole | 20 | $285 | $14 |
| Tamsulosin | 22 | $260 | $12 |
| Sulfamethoxazole-Trimethoprim | 24 | $155 | $6 |
| Benazepril | 11 | $106 | $10 |
| Minocycline | 11 | $95 | $9 |
| Isoniazid | 12 | $74 | $6 |
| Zolpidem | 12 | $62 | $5 |
| Diazepam | 14 | $43 | $3 |
2013: 32 drugs
| Truvada | 105 | $110,886 | $1,056 |
| Prezista | 50 | $49,959 | $999 |
| Reyataz | 46 | $47,196 | $1,026 |
| Norvir | 82 | $28,376 | $346 |
| Epzicom | 23 | $24,474 | $1,064 |
| Lexiva | 13 | $23,029 | $1,771 |
| Isentress | 21 | $22,936 | $1,092 |
| Intelence | 21 | $20,496 | $976 |
| Sustiva | 24 | $15,459 | $644 |
| Kaletra | 22 | $14,453 | $657 |
| Selzentry | 13 | $14,344 | $1,103 |
| Combivir | 12 | $10,181 | $848 |
| Viramune Xr | 13 | $7,849 | $604 |
| Ethambutol | 11 | $2,102 | $191 |
| Lamivudine | 12 | $2,041 | $170 |
| Avodart | 11 | $1,436 | $131 |
| Azithromycin | 19 | $1,338 | $70 |
| Atorvastatin | 52 | $1,076 | $21 |
| Famciclovir | 11 | $896 | $81 |
| Metronidazole | 16 | $808 | $50 |
| Proair Hfa | 17 | $802 | $47 |
| Acyclovir | 19 | $619 | $33 |
| Gabapentin | 11 | $590 | $54 |
| Fenofibrate | 13 | $496 | $38 |
| Glyburide | 12 | $423 | $35 |
| Clopidogrel | 16 | $313 | $20 |
| Sulfamethoxazole-Trimethoprim | 30 | $311 | $10 |
| Pantoprazole | 11 | $304 | $28 |
| Levothyroxine | 23 | $151 | $7 |
| Benazepril | 15 | $150 | $10 |
| Nortriptyline | 11 | $142 | $13 |
| Metformin | 13 | $69 | $5 |
Professional record
- NPI
- 1588628960
- Licence
- CA G60294California G60294: Current · expires 2027-02-28
- Trained
- University of Minnesota Medical School, 1985
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G602940
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X); Internal medicine (207R00000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-04-13
- NPI last updated
- 2012-01-13
This is when the NPI record was last certified, not a medical board exam.